rs745308973
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001377295.2(GNAT2):c.481C>T(p.Arg161Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,612,742 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001377295.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GNAT2 | NM_001377295.2 | c.481C>T | p.Arg161Ter | stop_gained | 6/9 | ENST00000679935.1 | NP_001364224.1 | |
GNAT2 | NM_001379232.1 | c.481C>T | p.Arg161Ter | stop_gained | 6/9 | NP_001366161.1 | ||
GNAT2 | NM_005272.5 | c.481C>T | p.Arg161Ter | stop_gained | 5/8 | NP_005263.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GNAT2 | ENST00000679935.1 | c.481C>T | p.Arg161Ter | stop_gained | 6/9 | NM_001377295.2 | ENSP00000505083 | P1 | ||
GNAT2 | ENST00000351050.8 | c.481C>T | p.Arg161Ter | stop_gained | 5/8 | 1 | ENSP00000251337 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152144Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251456Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135900
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1460598Hom.: 0 Cov.: 29 AF XY: 0.00000413 AC XY: 3AN XY: 726696
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152144Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74324
ClinVar
Submissions by phenotype
Achromatopsia 4 Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | May 03, 2020 | - - |
Pathogenic, no assertion criteria provided | research | Molecular Genetics Laboratory, Institute for Ophthalmic Research | Jun 12, 2018 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 25, 2022 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Identified in a patient with cone dystrophy in the literature, although additional clinical information was not provided (Kim et al., 2019); This variant is associated with the following publications: (PMID: 31589614, 31144483, 31058429) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 20, 2022 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 522772). This premature translational stop signal has been observed in individual(s) with GNAT2-related conditions (PMID: 31058429, 31144483). This variant is present in population databases (rs745308973, gnomAD 0.008%). This sequence change creates a premature translational stop signal (p.Arg161*) in the GNAT2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GNAT2 are known to be pathogenic (PMID: 12077706). - |
Achromatopsia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | Jan 09, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at